You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Details for New Drug Application (NDA): 202901

✉ Email this page to a colleague

« Back to Dashboard

NDA 202901 describes CHOLESTYRAMINE, which is a drug marketed by Aiping Pharm Inc, Ajanta Pharma Ltd, Alkem Labs Ltd, Ani Pharms, Epic Pharma Llc, Ivax Sub Teva Pharms, Macleods Pharms Ltd, Ph Health, Tagi, Teva, Zydus Pharms, Pharmobedient Cnsltg, and Teva Pharms, and is included in nineteen NDAs. It is available from ten suppliers. Additional details are available on the CHOLESTYRAMINE profile page.

The generic ingredient in CHOLESTYRAMINE is cholestyramine. There are eight drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.

Summary for 202901

Tradename:	CHOLESTYRAMINE
Applicant:	Zydus Pharms
Ingredient:	cholestyramine
Patents:	0

Pharmacology for NDA: 202901

Mechanism of Action	Bile-acid Binding Activity

Suppliers and Packaging for NDA: 202901

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
CHOLESTYRAMINE	cholestyramine	POWDER;ORAL	202901	ANDA	Zydus Pharmaceuticals (USA) Inc.	68382-528	68382-528-42	378 g in 1 CAN (68382-528-42)
CHOLESTYRAMINE	cholestyramine	POWDER;ORAL	202901	ANDA	Zydus Pharmaceuticals (USA) Inc.	68382-528	68382-528-60	60 POUCH in 1 CARTON (68382-528-60) / 9 g in 1 POUCH

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	POWDER;ORAL			Strength	EQ 4GM RESIN/SCOOPFUL
Approval Date:	Jul 2, 2018	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.